
News|Articles|February 13, 2019
- Drug Topics March 2019
- Volume 163
- Issue 3
Xofluza for Acute Uncomplicated Influenza
Author(s)Drew Boxler
Advertisement
Xofluza (baloxavir marboxil, Genetech)
Indications: acute uncomplicated influenza in patients 12+, <48hr symptomatic
Dosage:
- 40-80kg body = 40 mg
- 80kg+ = 80 mg
Contraindications: history of hypersensitivity to baloxair marboxil or any of its ingredients
Articles in this issue
over 7 years ago
Coping with Patient Deathover 7 years ago
Opinion: Why Change Is Like a Hemorrhoidectomyover 7 years ago
Pharmacists Want More Time with Patientsover 7 years ago
The Pros and Cons of Switching to a Health Systemover 7 years ago
Early Planning is Key to Retirement and Successionover 7 years ago
Dietary Supplements Need Evidence and Evaluationover 7 years ago
Reconnect to Reinvigorateover 7 years ago
Pharmacy Education for the 21st Centuryover 7 years ago
How to Achieve Balance in Work and in Lifeover 7 years ago
Case Studies in StabilityAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
3
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
4
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
5







































